ADAR1 Capital Management »

Bicycle Therapeutics shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Bicycle Therapeutics (BCYC) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Bicycle Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicycle Therapeutics held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicycle Therapeutics by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $359k 14k 24.90
2023-12-31 $2.3M 129k 18.08

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Bicycle Therapeutics

Baker Bros. Advisors
Deep Track Capital
RA Capital Management
Fcpm Iii Services B.v.
Armistice Capital
Westfield Capital Management Company
T. Rowe Price Associates
Morgan Stanley
First Light Asset Management
EcoR1 Capital
Point72 Asset Management
Bnp Paribas Investment Partners
Candriam Luxembourg S.C.A.
Parkman Healthcare Partners
Principal Financial Group

View all funds holding Bicycle Therapeutics